REGN 732.71997

Market Overview

Market Overview REGN closed at $741.91 on January 15, 2026, marking a slight increase of 0.04% from the previous close but continuing a downtrend over the past 30 days with a period return of -1.95%. The stock remains below its 20-day SMA of 748.99, 50-day DMA near 760 (not explicitly given but implied by resistance), and 200-day DMA, reflecting bearish momentum. The RSI indicates weakening buying pressure, with nearest support around $738.62 and resistance near $760. No specific upcoming events were noted, though clinical trial results and sector developments may influence price action. Technical indicators confirm the current downtrend. For information only. Last Updated 1/15/26